COLGATE PALMOLIVE CO Quarterly Cost of Revenue in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Colgate Palmolive Co quarterly/annual Cost of Revenue history and growth rate from Q1 2010 to Q2 2024.
  • Colgate Palmolive Co Cost of Revenue for the quarter ending June 30, 2024 was $1.99B, a 2.11% decline year-over-year.
  • Colgate Palmolive Co Cost of Revenue for the twelve months ending June 30, 2024 was $8.06B, a 0.01% increase year-over-year.
  • Colgate Palmolive Co annual Cost of Revenue for 2023 was $8.13B, a 5.34% increase from 2022.
  • Colgate Palmolive Co annual Cost of Revenue for 2022 was $7.72B, a 9.55% increase from 2021.
  • Colgate Palmolive Co annual Cost of Revenue for 2021 was $7.05B, a 9.17% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.06B $1.99B -$43M -2.11% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $8.1B $2.03B -$32M -1.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $8.13B $2B -$55M -2.68% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $8.19B $2.04B +$131M +6.87% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $8.06B $2.04B +$105M +5.44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $7.95B $2.06B +$231M +12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $7.72B $2.06B +$211M +11.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $7.51B $1.91B +$116M +6.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $7.39B $1.93B +$226M +13.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $7.17B $1.83B +$120M +7.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $7.05B $1.84B +$163M +9.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $6.88B $1.79B +$178M +11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $6.71B $1.7B +$176M +11.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $6.53B $1.71B +$75M +4.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $6.45B $1.68B +$80M +5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $6.37B $1.61B +$1M +0.06% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $6.37B $1.53B -$30M -1.93% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $6.4B $1.63B +$35M +2.19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $6.37B $1.6B +$43M +2.76% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $6.33B $1.61B +$36M +2.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $6.29B $1.56B -$27M -1.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $6.32B $1.6B +$3M +0.19% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $6.31B $1.56B -$6M -0.38% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $6.32B $1.58B -$15M -0.94% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $6.33B $1.59B +$59M +3.87% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $6.28B $1.59B +$101M +6.77% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q4 2017 $6.17B $1.56B +$90M +6.11% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $6.08B $1.59B +$48M +3.11% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $6.04B $1.53B -$15M -0.97% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $6.05B $1.49B -$21M -1.39% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $6.07B $1.47B -$132M -8.22% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-21
Q3 2016 $6.2B $1.54B -$109M -6.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $6.31B $1.54B -$158M -9.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-21
Q1 2016 $6.47B $1.51B -$164M -9.77% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $6.64B $1.61B -$140M -8.02% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-21
Q3 2015 $6.78B $1.65B -$169M -9.28% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $6.94B $1.7B -$101M -5.61% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $7.05B $1.68B -$123M -6.83% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $7.17B $1.75B -$48M -2.68% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $7.22B $1.82B +$8M +0.44% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $7.21B $1.8B -$12M -0.66% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $7.22B $1.8B +$1M +0.06% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $7.22B $1.79B +$13M +0.73% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 $7.21B $1.81B +$10M +0.56% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $7.2B $1.81B +$6M +0.33% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $7.19B $1.8B +$37M +2.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q4 2012 $7.15B $1.78B +$2M +0.11% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $7.15B $1.8B -$118M -6.14% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-24
Q2 2012 $7.27B $1.81B +$25M +1.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $7.24B $1.76B +$100M +6.01% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $7.14B $1.78B +$151M +9.28% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $6.99B $1.92B +$322M +20.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $6.67B $1.78B +$209M +13.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 $6.46B $1.66B +$102M +6.53% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $6.36B $1.63B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-21
Q3 2010 $1.6B Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $1.57B Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $1.56B Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.